Amdocs Stock Total Asset

DOX Stock

USD 85.20 1.47 1.76%

Amdocs fundamentals help investors to digest information that contributes to Amdocs' financial success or failures. It also enables traders to predict the movement of Amdocs Stock. The fundamental analysis module provides a way to measure Amdocs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amdocs stock.

	Last Reported	Projected for Next Year
Total Assets	7.4 B	4.5 B
Intangibles To Total Assets	0.41	0.33

Total Assets is likely to drop to about 4.5 B in 2024. Intangibles To Total Assets is likely to drop to 0.33 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Amdocs Company Total Asset Analysis

Amdocs' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Amdocs Total Asset

6.43 B

Most of Amdocs' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Amdocs Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Amdocs is extremely important. It helps to project a fair market value of Amdocs Stock properly, considering its historical fundamentals such as Total Asset. Since Amdocs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amdocs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amdocs' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Long Term Debt	Good Will	Intangible Assets	Property Plant Equipment	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Short Long Term Debt	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	0.2	0.77	0.05	0.93	0.94	0.81	0.04	0.94	0.53	0.53	0.92	-0.85	0.56	-0.15	-0.86	-0.59	-0.58	-0.58	0.58	0.52	-0.31	0.33
Total Stockholder Equity	0.96		-0.06	0.67	0.28	0.93	0.8	0.89	0.23	0.9	0.38	0.43	0.81	-0.93	0.35	-0.1	-0.82	-0.46	-0.48	-0.46	0.42	0.29	-0.25	0.19
Net Debt	0.2	-0.06		0.6	-0.72	0.13	0.48	-0.28	-0.52	0.26	0.41	0.64	0.45	0.2	0.85	-0.29	-0.37	-0.7	-0.64	-0.63	0.75	0.83	-0.46	0.59
Retained Earnings	0.77	0.67	0.6		-0.19	0.72	0.81	0.49	-0.12	0.85	0.54	0.79	0.81	-0.57	0.88	-0.19	-0.85	-0.81	-0.8	-0.7	0.85	0.75	-0.62	0.67
Accounts Payable	0.05	0.28	-0.72	-0.19		0.14	-0.2	0.4	0.12	0.07	-0.22	-0.19	-0.13	-0.34	-0.52	0.41	0.06	0.33	0.19	0.32	-0.4	-0.58	0.14	-0.27
Net Receivables	0.93	0.93	0.13	0.72	0.14		0.83	0.67	0.23	0.92	0.34	0.62	0.93	-0.82	0.42	-0.31	-0.89	-0.66	-0.67	-0.68	0.61	0.34	-0.49	0.26
Total Liab	0.94	0.8	0.48	0.81	-0.2	0.83		0.64	-0.18	0.89	0.64	0.58	0.93	-0.67	0.75	-0.18	-0.82	-0.67	-0.62	-0.64	0.7	0.73	-0.33	0.46
Total Current Assets	0.81	0.89	-0.28	0.49	0.4	0.67	0.64		0.15	0.72	0.43	0.09	0.52	-0.91	0.22	0.21	-0.55	-0.1	-0.12	-0.06	0.11	0.18	0.07	0.12
Short Term Debt	0.04	0.23	-0.52	-0.12	0.12	0.23	-0.18	0.15		0.05	-0.41	-0.03	0.0	-0.28	-0.44	-0.28	-0.15	0.1	0.02	-0.02	-0.15	-0.46	-0.01	-0.32
Common Stock	0.94	0.9	0.26	0.85	0.07	0.92	0.89	0.72	0.05		0.47	0.62	0.92	-0.78	0.62	-0.16	-0.83	-0.65	-0.67	-0.62	0.74	0.59	-0.48	0.57
Current Deferred Revenue	0.53	0.38	0.41	0.54	-0.22	0.34	0.64	0.43	-0.41	0.47		0.23	0.46	-0.34	0.65	0.34	-0.41	-0.3	-0.24	-0.15	0.33	0.52	-0.06	0.35
Long Term Debt	0.53	0.43	0.64	0.79	-0.19	0.62	0.58	0.09	-0.03	0.62	0.23		0.73	-0.24	0.66	-0.38	-0.8	-0.89	-0.99	-0.86	0.83	0.56	-0.62	0.46
Good Will	0.92	0.81	0.45	0.81	-0.13	0.93	0.93	0.52	0.0	0.92	0.46	0.73		-0.63	0.65	-0.35	-0.89	-0.8	-0.78	-0.79	0.79	0.62	-0.53	0.45
Intangible Assets	-0.85	-0.93	0.2	-0.57	-0.34	-0.82	-0.67	-0.91	-0.28	-0.78	-0.34	-0.24	-0.63		-0.26	-0.03	0.67	0.25	0.28	0.28	-0.25	-0.15	0.18	-0.13
Property Plant Equipment	0.56	0.35	0.85	0.88	-0.52	0.42	0.75	0.22	-0.44	0.62	0.65	0.66	0.65	-0.26		-0.13	-0.61	-0.72	-0.66	-0.6	0.82	0.92	-0.49	0.74
Short Term Investments	-0.15	-0.1	-0.29	-0.19	0.41	-0.31	-0.18	0.21	-0.28	-0.16	0.34	-0.38	-0.35	-0.03	-0.13		0.38	0.62	0.4	0.55	-0.44	-0.18	0.52	-0.02
Treasury Stock	-0.86	-0.82	-0.37	-0.85	0.06	-0.89	-0.82	-0.55	-0.15	-0.83	-0.41	-0.8	-0.89	0.67	-0.61	0.38		0.84	0.82	0.79	-0.69	-0.47	0.53	-0.25
Net Tangible Assets	-0.59	-0.46	-0.7	-0.81	0.33	-0.66	-0.67	-0.1	0.1	-0.65	-0.3	-0.89	-0.8	0.25	-0.72	0.62	0.84		0.91	0.87	-0.87	-0.63	0.73	-0.45
Deferred Long Term Liab	-0.58	-0.48	-0.64	-0.8	0.19	-0.67	-0.62	-0.12	0.02	-0.67	-0.24	-0.99	-0.78	0.28	-0.66	0.4	0.82	0.91		0.89	-0.86	-0.58	0.63	-0.47
Short Long Term Debt	-0.58	-0.46	-0.63	-0.7	0.32	-0.68	-0.64	-0.06	-0.02	-0.62	-0.15	-0.86	-0.79	0.28	-0.6	0.55	0.79	0.87	0.89		-0.83	-0.55	0.63	-0.35
Capital Surpluse	0.58	0.42	0.75	0.85	-0.4	0.61	0.7	0.11	-0.15	0.74	0.33	0.83	0.79	-0.25	0.82	-0.44	-0.69	-0.87	-0.86	-0.83		0.82	-0.73	0.79
Net Invested Capital	0.52	0.29	0.83	0.75	-0.58	0.34	0.73	0.18	-0.46	0.59	0.52	0.56	0.62	-0.15	0.92	-0.18	-0.47	-0.63	-0.58	-0.55	0.82		-0.32	0.79
Net Working Capital	-0.31	-0.25	-0.46	-0.62	0.14	-0.49	-0.33	0.07	-0.01	-0.48	-0.06	-0.62	-0.53	0.18	-0.49	0.52	0.53	0.73	0.63	0.63	-0.73	-0.32		-0.52
Capital Stock	0.33	0.19	0.59	0.67	-0.27	0.26	0.46	0.12	-0.32	0.57	0.35	0.46	0.45	-0.13	0.74	-0.02	-0.25	-0.45	-0.47	-0.35	0.79	0.79	-0.52

Click cells to compare fundamentals

Amdocs Total Asset Historical Pattern

Today, most investors in Amdocs Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Amdocs' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Amdocs total asset as a starting point in their analysis.

Amdocs Total Asset

Timeline

Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Competition

Predict Amdocs

Total Assets Over Time

Amdocs Total Assets

Total Assets

4.51 Billion

At this time, Amdocs' Total Assets are fairly stable compared to the past year.

Based on the latest financial disclosure, Amdocs has a Total Asset of 6.43 B. This is 90.26% lower than that of the IT Services sector and significantly higher than that of the Information Technology industry. The total asset for all United States stocks is 78.19% higher than that of the company.

Amdocs Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.

Amdocs is currently under evaluation in total asset category among its peers.

Amdocs ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.

Environmental

Governance

Social

Amdocs Institutional Holders

Institutional Holdings refers to the ownership stake in Amdocs that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amdocs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amdocs' value.

		Shares
Amvescap Plc.	2024-06-30	2.1 M
Wellington Management Company Llp	2024-06-30	2.1 M
American Century Companies Inc	2024-09-30	2 M
Dimensional Fund Advisors, Inc.	2024-09-30	2 M
State Street Corp	2024-06-30	1.7 M
Pacer Advisors, Inc.	2024-06-30	1.7 M
Nordea Investment Mgmt Bank Demark A/s	2024-09-30	1.5 M
Geode Capital Management, Llc	2024-06-30	1.5 M
Principal Financial Group Inc	2024-09-30	1 M
Fmr Inc	2024-09-30	16.9 M
Hhg Plc	2024-06-30	6.5 M

Amdocs Fundamentals

	Return On Equity	0.14
	Return On Asset	0.0738
	Profit Margin	0.1 %
	Operating Margin	0.15 %
	Current Valuation	9.81 B
	Shares Outstanding	115 M
	Shares Owned By Institutions	98.38 %
	Number Of Shares Shorted	2.86 M
	Price To Earning	19.03 X
	Price To Book	2.76 X
	Price To Sales	1.92 X
	Revenue	4.89 B
	Gross Profit	1.62 B
	EBITDA	855.15 M
	Net Income	542.96 M
	Cash And Equivalents	817.98 M
	Cash Per Share	6.74 X
	Total Debt	807.31 M
	Debt To Equity	0.23 %
	Current Ratio	1.60 X
	Book Value Per Share	30.39 X
	Cash Flow From Operations	822.63 M
	Short Ratio	6.06 X
	Earnings Per Share	4.29 X
	Price To Earnings To Growth	1.08 X
	Target Price	100.29
	Beta	0.75
	Market Capitalization	9.63 B
	Total Asset	6.43 B
	Retained Earnings	6.55 B
	Working Capital	558.25 M
	Current Asset	2.1 B
	Current Liabilities	1.37 B
	Annual Yield	0.02 %
	Five Year Return	1.73 %
	Net Asset	6.43 B
	Last Dividend Paid	1.87

About Amdocs Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amdocs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC